Browse by Medical Category
Not Accepting New Patients
Dr. Cusin's focus is Treatment Resistant Depression, she is involved in research trials on treatments for TRD. She was part of the pivotal trial investigating Deep Brain Stimulation for the most treatment-refractory forms of depression. She provides expert consultation for patients with treatment-refractory mood disorders.
Accepting patients by clinician referral only. Please check with our practice to confirm your insurance eligibility as it may change
Go To Programs
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Cusin's field of interest is Treatment Resistant Depression (TRD).
At the Depression Clinical & Research Program (DCRP), she is involved in numerous clinical trials, sponsored by NIMH and foundations, investigating new pharmacologic treatments for Major Depression and TRD, including intravenous administration of ketamine and scopolamineShe is one of the programmers in the pivotal trial for Deep Brain Stimulation for MDD sponsored by Medtronic, for patients affected by extremely treatment-refractory depression.
Dr. Cusin is also developing two original projects aiming at detecting possible neurobiological mechanisms of placebo response in antidepressant clinical trials.
View my most recent publications at PubMed
A study led by Massachusetts General Hospital investigators identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.
Back to Top